Kukje Pharma Co., Ltd. (KRX: 002720)

Kukje Pharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 14, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	117,899	119,890	106,115	112,861	176,865	81,078
Market Cap Growth	39.06%	12.98%	-5.98%	-36.19%	118.14%	8.62%
Enterprise Value	138,722	140,751	127,215	143,804	207,752	109,723
Last Close Price	5790.00	5920.00	5238.10	5569.16	8724.76	3999.57
PE Ratio	-	-	29.83	-	80.28	-
PS Ratio	0.82	0.89	0.84	0.94	1.36	0.73
PB Ratio	1.33	1.41	1.43	1.65	2.51	1.33
P/TBV Ratio	1.33	1.43	1.45	1.67	2.54	1.35
P/FCF Ratio	-	47.40	20.23	14.65	-	-
P/OCF Ratio	6527.08	33.53	16.32	11.76	34.68	22.50
EV/Sales Ratio	0.97	1.04	1.00	1.20	1.59	0.99
EV/EBITDA Ratio	45.86	63.54	13.03	52.42	21.49	12.45
EV/EBIT Ratio	-	-	24.13	-	34.39	19.73
EV/FCF Ratio	-75.93	55.65	24.25	18.66	-	-
Debt / Equity Ratio	0.31	0.36	0.39	0.52	0.54	0.58
Debt / EBITDA Ratio	9.14	13.84	2.93	13.12	3.94	4.04
Debt / FCF Ratio	-	12.12	5.45	4.67	-	-
Asset Turnover	0.94	0.90	0.92	0.84	0.93	0.85
Inventory Turnover	3.25	3.13	3.27	3.42	3.43	3.78
Quick Ratio	0.58	0.53	0.54	0.58	0.51	0.74
Current Ratio	1.07	0.92	1.01	0.88	0.90	1.03
Return on Equity (ROE)	0.47%	-10.58%	4.97%	-2.24%	3.34%	-7.35%
Return on Assets (ROA)	-0.25%	-0.83%	2.38%	-0.73%	2.69%	2.67%
Return on Capital (ROIC)	-0.35%	-1.14%	3.18%	-0.98%	3.68%	3.58%
Earnings Yield	0.29%	-7.02%	3.35%	-1.38%	1.25%	-5.87%
FCF Yield	-1.55%	2.11%	4.94%	6.83%	-3.67%	-2.82%
Buyback Yield / Dilution	0.02%	0.03%	0.03%	0.02%	0.00%	0.02%
Total Shareholder Return	0.02%	0.03%	0.03%	0.02%	0.00%	0.02%

Source: S&P Capital IQ. Standard template. Financial Sources.